Targeted agents in metastatic Xp11 translocation/TFE3 gene fusion renal cell carcinoma (RCC): a report from the Juvenile RCC Network.

Malouf, G G

Targeted agents in metastatic Xp11 translocation/TFE3 gene fusion renal cell carcinoma (RCC): a report from the Juvenile RCC Network. [electronic resource] - Annals of oncology : official journal of the European Society for Medical Oncology Sep 2010 - 1834-1838 p. digital

Publication Type: Journal Article

1569-8041

10.1093/annonc/mdq029 doi


Adolescent
Adult
Antineoplastic Agents--therapeutic use
Antiviral Agents--therapeutic use
Basic Helix-Loop-Helix Leucine Zipper Transcription Factors--genetics
Benzenesulfonates--therapeutic use
Carcinoma, Renal Cell--drug therapy
Child
Child, Preschool
Chromosomes, Human, Pair 11--genetics
Chromosomes, Human, X--genetics
Everolimus
Female
Gene Fusion
Humans
Immunosuppressive Agents--therapeutic use
Indoles--therapeutic use
Interferon-alpha--therapeutic use
Kidney Neoplasms--drug therapy
Male
Middle Aged
Niacinamide--analogs & derivatives
Phenylurea Compounds
Pyridines--therapeutic use
Pyrroles--therapeutic use
Research Report
Retrospective Studies
Sirolimus--analogs & derivatives
Sorafenib
Sunitinib
Survival Rate
TOR Serine-Threonine Kinases--antagonists & inhibitors
Translocation, Genetic--genetics
Treatment Outcome
Vascular Endothelial Growth Factor A--antagonists & inhibitors
Young Adult